You are here:Home-ADCs and PROTACs-PROTAC-JET-209
JET-209

Chemical Structure : JET-209

CAS No.:

JET-209 (JET209, JET 209)

Catalog No.: PC-20885Not For Human Use, Lab Use Only.

JET-209 (JET209) is a potent, selective PROTAC degrader of CBP/p300 based on GNE-207 with DC50 of 0.05 nM for CBP and 0.2 nM for p300, Dmax >95% for both proteins in the RS4;11 leukemia cell line.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

JET-209 (JET209) is a potent, selective PROTAC degrader of CBP/p300 based on GNE-207 with DC50 of 0.05 nM for CBP and 0.2 nM for p300, Dmax >95% for both proteins in the RS4;11 leukemia cell line.
JET-209 is extremely potent and effective in the inhibition of cell growth in the RS4;11 cell line with IC50 = 0.1 nM and Imax ≥ 94%.
JET-209 is also effective in the induction of cell cycle arrest in the RS4;11 cell line.
JET-209 is at least 1000 times more potent than CCS1477 and A-485 in inducing G1 cell cycle arrest in the RS4;11 cell line.
JET-209 is also a very potent inhibitor of cell growth in the MV4;11, HL-60, and MOLM-13 acute leukemia cell lines, achieving IC50 values of 0.04, 0.54, and 2.3 nM, respectively.
JET-209 potently and effectively suppresses the expression of MYC and MYB genes in the RS4;11 cell line.
JET-209 effectively depletes CBP/p300 proteins in RS4;11 xenograft tumors in mice, JET-209 (1 mg/kg twice a week or 3 mg/kg weekly for 2 weeks, IP injection) effectively inhibits tumor growth in xenograft tumor models.

Physicochemical Properties

M.Wt 821.94
Formula C46H47N9O6
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

O=C(NC1CCN(C2=CC3=C(C(N(C(CC4)C(NC4=O)=O)C3)=O)C=C2)CC1)C5=NC=C(C6=CC7=C(C=N6)C(C8=NN(C9CCOCC9)C%10=C8CN(C(C)=O)CC%10)=CC=C7)C=C5

References

1. Junius Eugene Thomas II, et al. Journal of Medicinal Chemistry, June 5, 2023

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: